Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multicenter Randomized Openlabel Study to Evaluate the Benefit on Renal Function at 12months Post-transplantation of Immunosuppressive Treatment With Withdrawal of Calcineurin Inhibitor at 3months and Combining Mycophenolate Sodium-Everolimus Versus Tacrolimus-Everolimus, in Patients With de Novo Kidney Transplant

NCT02334488 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT02334488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02334488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multicenter Randomized Openlabel Study to Evaluate the Benefit on Renal Function at 12months Post-transplantation of Immunosuppressive Treatment With Withdrawal of Calcineurin Inhibitor at 3months and Combining Mycophenolate Sodium-Everolimus Versus Tacrolimus-Everolimus, in Patients With de Novo Kidney Transplant
Lead sponsor
Poitiers University Hospital
Phase
Phase 3
Overall status
Completed
Start date
December 11, 2014
Completion date
July 3, 2020
Enrollment
329 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease